EOM Pharmaceuticals Holdings, Inc.
IMUC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $19 | $26 | $93 | $19 |
| - Cash | $0 | $0 | $1 | $1 |
| + Debt | $0 | $5 | $3 | $3 |
| Enterprise Value | $20 | $31 | $96 | $20 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$1 | -$2 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$3 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.016 | -0.014 | -0.023 | -0.059 |
| % Growth | -15.5% | 39.3% | 60.3% | – |
| Operating Cash Flow | -$3 | -$1 | -$3 | -$2 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$1 | -$3 | -$2 |